Restoring sight with an artificial, full thickness corneal replacement скачать в хорошем качестве

Restoring sight with an artificial, full thickness corneal replacement

Every year, 2 million people develop corneal blindness, but only about 200,000 undergo a corneal transplantation to regain their vision. Almost 13 million people are on waiting lists for donor tissue, and even if they obtain it, the rejection rate for corneal replacements climbs from 10% in the first two years to almost 50% by year 15. Existing corneal alternatives (keratoprostheses) are last resort options for sight restoration. None are standard of care treatments due to complications including inflammation, infection, extrusion, opacification, and glaucoma. BioLattice Ophthalmics, Inc. is developing CorneaClear™, a synthetic, room-temperature-stable, biocompatible material that could expand access to corneal replacement surgery and outperform donor tissues and existing keratoprostheses.